ArticleBiomedicines2021

Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo.

Venugopal R Bovilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.